Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK population

Lorenzo Ficorella & Antonis C. Antoniou et al. · 2025-07-17

Abstract

Background

BOADICEA is a widely used algorithm for predicting breast and ovarian cancer risks, using a combination of genetic and lifestyle, hormonal and reproductive risk factors. However, it has largely been developed using data from White/European individuals, limiting its applicability to other ethnicities. Here, we updated BOADICEA to provide ethnicity-specific risk estimates.

Methods

We utilised data from multiple sources to derive estimates for the distributions and effect sizes of risk factors in major UK ethnic groups (White, Black, South Asian, East Asian, and Mixed), along with ethnicity-specific population cancer incidences. We also developed a method for deriving adjusted polygenic scores for individuals of mixed genetic ancestry.

Results

The predicted average absolute risks were smaller in all non-White ethnic groups than in Whites, and the risk distributions were narrower. The proportion of women classified as at moderate or high risk of breast or ovarian cancer, according to national guidelines, was considerably smaller in non-Whites.

Discussion

The updated BOADICEA, available in the CanRisk tool ( www.canrisk.org ), is based on more appropriate estimates for non-White women in the UK. Further validation of the model in prospective studies is required. Considering these findings, risk classification guidelines for non-White women may need to be revised.

Funding

Wellcome Trust (Wellcome)

v203477/Z/16/Z

Cancer Research UK (CRUK)

Catalyst Award CanGene-CanVar (C61296/A27223)

Cancer Research UK (CRUK)

PPRPGM-Nov20\100002

Cancer Research UK (CRUK)

grants PPRPGM-Nov20\100002 and SEBCD3-2024/100001

MOH | National Medical Research Council (NMRC)

Clinician Scientist Award (SI Category)

Wellcome Trust

Genome Canada (Génome Canada)

#13529

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)

grants 633784 (B-CAST) and 634935 (BRIDGES)

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada)

#155865

Cancer Research UK (CRUK)

grant PPRPGM-Nov20\100002